Related Experiment Videos
A urokinase receptor-associated protein with specific collagen binding properties
N Behrendt1, O N Jensen, L H Engelholm
1Finsen Laboratory, Rigshospitalet, DK-2100 Copenhagen O, Denmark. niels.behrendt@finsenlab.dk
The Journal of Biological Chemistry
|January 15, 2000
Summary
Researchers identified a novel protein, uPARAP, that interacts with urokinase and its receptor. This protein binds collagen V, potentially influencing cell adhesion and extracellular matrix degradation during tissue remodeling.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- The plasminogen activation system is crucial for extracellular proteolysis and tissue remodeling.
- Urokinase and its receptor (uPAR) are key regulators of this system.
- Understanding interactions at the cell surface is vital for comprehending tissue remodeling processes.
Purpose of the Study:
- To identify novel molecular interaction partners of urokinase and its receptor on the cell surface.
- To characterize the function of newly identified proteins involved in the plasminogen activation cascade.
Main Methods:
- Covalent protein cross-linking combined with mass spectrometry.
- Peptide mapping and primary structure analysis of protein conjugates.
- Nanoelectrospray tandem mass spectrometric sequencing for protein identification.
- cDNA cloning and sequencing.
Main Results:
- A specific tri-molecular complex involving urokinase receptor, pro-urokinase, and a novel protein was identified.
- The novel protein, uPARAP, was identified as the human homologue of a murine membrane-bound lectin.
- uPARAP belongs to the macrophage mannose receptor protein family and contains collagen-binding domains.
- uPARAP strongly binds collagen V at the site of plasminogen activation.
Conclusions:
- uPARAP is a novel urokinase receptor-associated protein involved in extracellular proteolysis.
- Its collagen V binding suggests roles in cell adhesion and matrix degradation.
- uPARAP may modulate tissue remodeling through its interaction with the plasminogen activation system.